867:HKEXChina Medical System Holdings Ltd. Analysis

The stock is trading at MYR 0.195, just above the calculated support of MYR 0.195 and below the 20‑day SMA of MYR 0.201, indicating limited upside in the near term. RSI sits at 38.7, hinting at mild oversold conditions, while the MACD histogram is negative and the signal line is bearish, suggesting downward momentum may persist despite the recent increase in volume and a Fear & Greed index of 72.88 (Greed).
Fundamentally, the company posted a 15.9% revenue decline, negative operating (‑27.7%) and profit margins (‑22.9%), and an EBITDA loss of MYR 6.19 million, with a debt‑to‑equity ratio of 21.2 indicating a heavily leveraged balance sheet. The price‑to‑book of 0.19 and DCF fair value of MYR 0.2003 suggest the market is pricing the stock slightly below intrinsic value, but the lack of dividend, high 30‑day volatility (≈40.6%), and a max drawdown of ‑36.5% amplify the risk profile.